Skip to main content
SpringerLink
Log in

Azapropazone in gout and hyperuricaemia

  • Chapter
Azapropazone

  • 54 Accesses

Abstract

After 20 years of clinical use as a non-steroidal anti-inflammatory drug (NSAID) azapropazone is now well established as both a useful agent for treating attacks of acute gouty arthritis and as single agent interval therapy for the management of patients with hyperuricaemia and recurrent gouty arthritis where uric acid lowering drug therapy is indicated

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Frank, K.O. (1971). Investigation of the uricosuric action of azapropazone. Z. Rheumaforsch., 30, 368–373

    CAS  Google Scholar 

  2. Thomas, A.L., Majoos, F.L. and Nuki, G. (1983). Preliminary studies with azapropazone in gout and hyperuricaemia. Eur. J. Rheumatol. Inflamm., 6, 149–154

    PubMed  CAS  Google Scholar 

  3. Herne, N., Hugny, D., Hauteville, D., Desbaumes, J., De Muizon, H. and Andran, M. (1977). L’azapropazone, Etude de son activite hypouricemiante. Nouv. Presse. Med., 6, 1657–1658

    Google Scholar 

  4. Dieppe, P.A., Doherty, M., Whicher, J.T. and Walters, G. (1977). The treatment of gout with azapropazone: clinical and experimental studies. Eur. J. Rheumatol. Inflamm., 4, 392–400

    Google Scholar 

  5. Higgen, C.S. and Scott, J.T. (1984). The uricosuric action of azapropazone: dose response and comparison with probencid. Br. J. Clin. Pharmacol, 18, 439–443

    Google Scholar 

  6. Steele, T.H. (1973). Urate secretion in man: the pyrazinamide suppression test. Ann. Intern. Med., 79, 734–737

    PubMed  CAS  Google Scholar 

  7. Kippin, I., Whitehouse, M.W. and Klinenberg, J.R. (1974). Pharmacology of uricosuric drugs. Ann. Rheum. Dis., 33, 391–393

    Article  Google Scholar 

  8. Postelethwaite, A.E., Gutman, R.A. and Kelley, W.N. (1974). Salicylate mediated increase in uric acid removal during haemodialysis: evidence for urate binding in vivo. Metabolism, 23, 771–777

    Article  Google Scholar 

  9. Jahn, U. and Thiele, K. (1988). In-vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy azapropazone. Arzneim. Forsch., 38, 507–508

    CAS  Google Scholar 

  10. Gibson, T., Simmonds, H.A., Armstrong, R.D., Fairbanks, L.D. and Rogers, A.V. (1984). Azapropazone — a treatment of hyperuricaemia and gout? Br. J. Rheumatol., 23, 44–51

    Article  PubMed  CAS  Google Scholar 

  11. Rylance, HJ., Wallace, R.C. and Nuki, G. (1983). Analysis of human plasma and urine purines using high performance liquid chromatograghy. Ann. Rheum. Dis., 42, (Suppl), 85

    Article  Google Scholar 

  12. Sorenson, C.B. (1965). Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum., 8, 694–703

    Article  Google Scholar 

  13. Frank, O. (1976). The treatment of acute gouty arthritis. J. Clin. Chem. Clin. Biochem., 14, 290

    Google Scholar 

  14. Dunky, A., Bartsch, G. and Eberl, R. (1984). The intravenous application of azapropazone in the treatment of acute gout. Arthritis Rheum., 6, 1–6

    Google Scholar 

  15. Thompson, M., Sanders, P.A., Walker, D.J. and Templeton, J.S. (1985). Abst. XVIth International Congress Rheumatology, Sydney

    Google Scholar 

  16. Brune, K, Rainsford, K.D., Wagner, K. and Peskar, B.A. (1981). Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedeberg’s Arch. Pharmacol., 315, 269–281

    Article  CAS  Google Scholar 

  17. Lewis, D.A., Capstick, R.B. and Ancill, R.J. (1971). The action of azapropazone, oxyphenbutazone and phenylbutazone on lysosomes. J. Pharm. Pharmacol., 23, 931

    Article  PubMed  CAS  Google Scholar 

  18. Mackin, W.M., Rakich, S.M. and Marshall, C.L. (1986). Inhibition of rat neutrophil functional responses by azapropazone, an anti-gout drug. Biochem. Pharmacol, 35, 917–922

    Article  PubMed  CAS  Google Scholar 

  19. Palit, J., Nuki, G. (Unpublished observations)

    Google Scholar 

  20. Bell, A.L, Hurst, N.P, French, J.K., Adamson, J. and Nuki, G. (1987). Effects of non-steroidal anti-inflammatory drugs and antimalarial agents on blood monocyte superoxide anion production in vitro and ex vivo in rheumatoid arthritis. In: A.J.G. Swaark and J.K. Forster, (eds.) Free Radicals and Arthritis Diseases., Topics in Ageing Research in Europe. 11, 151–160

    Google Scholar 

  21. Thomas, A. and Nuki, G. (1979). The hypouricaemic effects of azapropazone and phenylbutazone. XIXth European Congress Rheumatology, Wiesbaden

    Google Scholar 

  22. Templeton, J.S. (1983). Longterm comparison of azapropazone with allopurinol in control of chronic gout and hyperuricaemia. Ann. Rheum. Dis., 42 (Suppl. 1), 92–93

    Article  Google Scholar 

  23. Fraser, R.C, Harvard-Davis, R. and Walker, F.S. (1987). Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia. J. Roy. Coll. Gen. Practit., 37, 409–411

    CAS  Google Scholar 

Download references

Authors
  1. G. Nuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Grinlinton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Palit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biomedical Sciences, McMaster University Faculty of Health Sciences, 1200 Main St W, Hamilton, Ontario, L8N 3Z5, Canada

    K. D. Rainsford

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Nuki, G., Grinlinton, F., Palit, J., Wallace, R. (1989). Azapropazone in gout and hyperuricaemia. In: Rainsford, K.D. (eds) Azapropazone. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0713-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0713-3_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6806-2

  • Online ISBN: 978-94-009-0713-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation